paramethasone has been researched along with Metabolic Diseases in 2 studies
Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fiegel, G | 1 |
Kukwa, D | 1 |
Henrard, JC | 1 |
1 trial available for paramethasone and Metabolic Diseases
Article | Year |
---|---|
[Comparative studies on the effect of different glucocorticoids in the corticoid glucose tolerance test].
Topics: Betamethasone; Blood Glucose; Clinical Trials as Topic; Dexamethasone; Diabetes Mellitus; Fluprednis | 1969 |
1 other study available for paramethasone and Metabolic Diseases
Article | Year |
---|---|
[Current antalgic anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents; Betamethasone; Cortisone; Dexamethasone; Endocrine System Diseases; Eye Di | 1970 |